Utility of polygenic embryo screening for disease depends on the selection strategy

Todd Lencz(Feinstein Institute for Medical Research), Shai Carmi(Hebrew University of Jerusalem), Adam Green(Morgan Adams Foundation), Kyle Gettler(Icahn School of Medicine at Mount Sinai), Omer Weissbrod(Harvard University), Or Zuk(Broad Institute), Daniel Backenroth(Janssen (Belgium)), Einat Granot‐Hershkovitz(Hebrew University of Jerusalem), Judy H. Cho(Cedars-Sinai Medical Center)
eLife
October 11, 2021
Cited by 74


Related Papers